| Opioids and myocardial reperfusion injury. | |
| | |
MedLine Citation:
|
PMID: 17536429 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
It is well-established that reperfusion is the major method of salvaging ischemic myocardium following prolonged coronary artery occlusion, although the idea of reperfusion injury remains controversial. Moreover, more recent evidence strongly suggests that reperfusion per se is thought to result in further damage to the myocardium and blood vessel endothelium by various biochemical and physical factors including a burst of oxygen-derived free radicals (ROS), cellular or mitochondrial calcium overload and shear stress, to name a few. This has been termed lethal reperfusion injury. It has become increasingly evident that strategies in which interventions are administered during the early stages of reperfusion produce a reduction in reperfusion-mediated damage primarily by reducing massive calcium overload or by altering the intracellular milieu (pH, osmotic stress, etc.) and ROS release upon reperfusion. Furthermore, it is apparent that activation of blood borne elements such as neutrophils and macrophages and factors released by these cells such as cytokines may be responsible for a continuing expansion of infarction in the hours or even days following timely reflow and that inhibiting these factors may attenuate reperfusion injury. The present review will focus on the effect of endogenous and exogenous opioids on ischemic and reperfusion injury since these compounds are routinely used in the surgical arena and may have unappreciated cardioprotective effects in this subset of patients. Particular emphasis will be on the role of opioids in reperfusion injury and their relationship to the newly discovered phenomenon of postconditioning. |
| | |
Authors:
|
G J Gross; J N Peart |
Related Documents
:
|
23357149 - Effect of specific lipoprotein(a) apheresis on coronary atherosclerosis regression asse... 23649409 - Volatile substance misuse: an updated review of toxicity and treatment. 1845919 - Role of oxygen free radicals in ischemic and reperfused myocardium. 2529549 - Role of thromboxane receptor antagonists in cardiovascular disease. 6331179 - Myocardial alterations due to free-radical generation. 7912169 - Effects of oxidant exposure on substrate utilization and high-energy phosphates in isol... 1850589 - Cytomegalovirus endomyocarditis in a transplanted heart. a case report with in situ hyb... 15316309 - Isolated right ventricular failure in scleroderma heart disease. 22861049 - Ventricular septal defect in a ferret (mustela putorius furo). |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Review |
Journal Detail:
|
Title: Archives des maladies du coeur et des vaisseaux Volume: 100 ISSN: 0003-9683 ISO Abbreviation: Arch Mal Coeur Vaiss Publication Date: 2007 Mar |
Date Detail:
|
Created Date: 2007-05-31 Completed Date: 2007-06-19 Revised Date: 2009-02-13 |
Medline Journal Info:
|
Nlm Unique ID: 0406011 Medline TA: Arch Mal Coeur Vaiss Country: France |
Other Details:
|
Languages: eng Pagination: 231-7 Citation Subset: IM |
Affiliation:
|
Medical College of Wisconsin, Department of Pharmacology and Toxicology, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Analgesics, Opioid
/
administration & dosage,
therapeutic use* Animals Humans Myocardial Ischemia / therapy Myocardial Reperfusion / methods Myocardial Reperfusion Injury / prevention & control* Protective Agents / administration & dosage, therapeutic use Signal Transduction / physiology Time Factors |
| Grant Support | |
ID/Acronym/Agency:
|
HL08311/HL/NHLBI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Analgesics, Opioid; 0/Protective Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: T-tubules: a key structure of cardiac function and dysfunction.
Next Document: Cardiac myosin-binding protein C in the heart.